Novo Nordisk A/S Class B Profit Margin

As of the most recent data (June 2026), NONOF shows a profit margin of 35.35%. That compares with 35.61% in the prior-year period — down 0.7% year over year. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NONOF's profit margin is now 35.35% (was 35.61%) — a 0.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S Class B is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Novo Nordisk A/S Class B is at 35.35%, which is higher that average. That is roughly 65.7% above the sector mean. Use the comparison chart on this page to see how NONOF stacks up against individual peers as well.

That compares with 35.61% in the prior-year period — down 0.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Novo Nordisk A/S Class B with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Novo Nordisk A/S Class B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 35.35%) with ownership activity and broader fundamentals.